Jian Kang Zhang
Director/Board Member bei SIRNAOMICS LTD.
Profil
Jian Kang Zhang is currently the President, Chief Executive Officer & Director at Shanghai Zerun Biotechnology Co., Ltd.
He is also the Staff Director & Vice President at Walvax Biotechnology Co., Ltd.
since 2020 and the Non-Executive Director at Sirnaomics Ltd.
since 2021.
Previously, he served as an Independent Director at Shanghai Serum Bio-Technology Co., Ltd.
from 2017 to 2023 and as the Chief Operating Officer & Executive Vice President at Ustar Biotechnologies (Hangzhou) Ltd.
from 2017 to 2019.
Mr. Zhang completed his graduate degree from Dominican University (Illinois) in 1992, his MBA from China Europe International Business School in 2000, and his undergraduate degree from Fudan University in 1982.
Aktive Positionen von Jian Kang Zhang
| Unternehmen | Position | Beginn |
|---|---|---|
| SIRNAOMICS LTD. | Director/Board Member | 12.07.2021 |
| WALVAX BIOTECHNOLOGY CO., LTD. | Director/Board Member | 29.05.2020 |
Shanghai Zerun Biotechnology Co., Ltd.
 Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Jian Kang Zhang
| Unternehmen | Position | Ende |
|---|---|---|
| SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD. | Director/Board Member | 01.12.2023 |
Ustar Biotechnologies (Hangzhou) Ltd.
 Ustar Biotechnologies (Hangzhou) Ltd. Medical SpecialtiesHealth Technology Ustar Biotechnologies (Hangzhou) Ltd. develops and manufactures molecular diagnostic products. Its products include DNA extraction, TB testings, STD testings and DNA detection. The company was founded by Qimin You and Michael Hu in 2005 and is headquartered in Hangzhou, China. | Chief Operating Officer | 01.08.2019 |
Ausbildung von Jian Kang Zhang
| Dominican University (Illinois) | Graduate Degree |
| China Europe International Business School | Masters Business Admin |
| Fudan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Health Technology |
| SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD. | Health Technology |
| SIRNAOMICS LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Health Technology |
Ustar Biotechnologies (Hangzhou) Ltd.
Ustar Biotechnologies (Hangzhou) Ltd. Medical SpecialtiesHealth Technology Ustar Biotechnologies (Hangzhou) Ltd. develops and manufactures molecular diagnostic products. Its products include DNA extraction, TB testings, STD testings and DNA detection. The company was founded by Qimin You and Michael Hu in 2005 and is headquartered in Hangzhou, China. | Health Technology |
